Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Adv Chronic Kidney Dis. 2022 Mar;29(2):188–200.e1. doi: 10.1053/j.ackd.2021.09.002

Table 2.

Recommendation on Cancer Screening After Kidney Transplantation

Screening KDIGO AST
Skin/lip Annual examination Annual examination
Anogenital Annual examination
Pelvic exam/Pap smear Every 3 years Annually
Mammogram Annually > age 40 Every 1-2 years
PSA/DRE Not recommended Annually age > 50
Colorectal Same as general population Same as general population
Lymph node exam Every 3 months in the first year then annually

Abbreviations: AST, American Society of Transplantation; DRE, digital rectal exam; KDIGO, Kidney Disease: Improving Global Outcomes; PSA, prostate-specific antigen.